Find Tech Calls related to Medical Health, Medical, Health, Anatomy, Physiology, Oncology, Pharmaceuticals, Biotechnology and Immunology posted on Innoget
Organization from Switzerland posted this Technology CallSeeking compound libraries for a high throughput screening to develop new productsThe company is interested in library partners for rapid compound screening for it's new highly-flexible high throughput experimentation laboratory. This laboratory is designed with a plug-and-play concept, which allows quick integration of specialized workstations to automate each specific workflow. Now the company is looking for compound libraries as basis for a high throughput screening to develop new products for their businesses. For this purpose, they are seeking both synthetic and natural molecule collections and is open to partners from any country. While the company itself is interested to exploit the results of the screening a variety of cooperation is possible. Research cooperation agreements with research organizations might yield into publications or consequent R&D contracts. Technical cooperation with large libraries might help the libraries to describe their portfolio much more in detail or exclusively sell library components to the company. Depending on the development stage of the library compounds licensing compounds to the company might be an option. Depending on joint interests and capacities joint venture might be a way to further develop usability of compounds.
Organization from France posted this Technology CallSeeking for a surface decontamination processSpecialized in the food industry process we are constantly seeking for new and more efficient surface disinfection methods able to remove microbiological risks.
Juli Ramon posted this Technology Call
Account Manager at GCCIR
Louise Broitman posted this Technology Call
Owner at Haute Goodies
Organization from European Union posted this Technology CallSeeking Mahuannin B, F, and A from Ephedra Radix plantOne or more of the molecules Mahuannin B, F, and A from Ephedra Radix plant should be provided in one of the following forms: 1- Synthetically pure molecules 2- Enriched fractions of the plant extract 3- Isolated fraction from plant extract
Stephen O'Connor posted this Technology Call
Open Innovation Manager at PepsiCo
Alexander Kvashnin posted this Technology Call
Director at Center for Technology Transfer and Commercialization of Novosibirsk State University